WA-AUTH0
12.1.2022 14:02:05 CET | Business Wire | Press release
Auth0 , a product unit within Okta (NASDAQ: OKTA), today released the findings of its first Public Sector Identity Index , a global research report that provides government technology leaders with insight into the identity maturity of public sector organizations around the world. The report highlights the importance of a centralized identity strategy in putting safe and accessible services into the hands of citizens faster.
Over the past two years, many public sector organizations were prompted by the immediate need to deploy digital infrastructure to maintain continuity of their services amid the COVID-19 pandemic — such as offering citizens license renewals online and virtual education — and are now grappling with the impacts on cybersecurity and user experience. From the Executive Order on ‘Improving the Nation’s Cybersecurity’ in the U.S., to digital identity and Single Sign-On (SSO) initiatives in the UK and Australia, enabling employees, citizens, and other government entities to access all of these applications easily and securely has become a demand around the world.
The 2022 Public Sector Identity Index, conducted by Auth0 and Market Connections , captures the perceptions of 850 IT and line of business decision-makers within national and state/local government organizations across the U.S., UK, and ANZ (Australia and New Zealand) with regard to their Identity and Access Management (IAM) strategy.
The report’s key findings include:
- Only one in five are extremely confident in either the security (17%) or ease of use (19%) of their current authentication solution.
- Username and password is the most frequently used authentication method by citizens (86%), compared to very little usage of biometric or passwordless authentication (16%).
- Four in ten are currently building their own IAM solution in-house (41%), and cite speed to implementation (83%) and using internal staff to manage IAM internally (82%) as two of the biggest pain points in doing so.
- Most governments are looking to expand their digital services in the next two years (75%) and rank protecting citizen’s privacy and data as most important when thinking about citizen services (73%).
Regional analysis shows U.S. respondents rank ensuring citizens’ trust in digital services as an area of high importance (71%), but have less confidence in their organization’s ability to deliver this (56%). Similar discrepancies in importance versus confidence in delivery include speed in adding new services in the UK (66% importance vs. 48% confidence), and improving the user experience in ANZ (72% importance vs. 60% confidence).
Dean Scontras, Vice President of State and Local Government and Education (SLED) at Okta, said: “Digitization is likely to continue in light of Zero Trust mandates and mounting consumer expectations. Public sector organizations greatly benefit from bringing their identity management strategy in line with their digital goals. While there is a strong focus on securing citizen data, the vast majority of applications are still protected by a username and password, despite their well-documented security risks.”
According to Forrester Research, the public sector has a massive influence on the entire economy making up 30% of the global GDP and 33% of the global workforce, and the global research firm predicts that more governments will adopt Zero Trust frameworks to revive public trust in digital services.1
An Identity-First approach puts identity at the center of government digital transformation, while also laying the foundation for a Zero Trust security model. Key to this approach are modern login technologies that replace traditional passwords, and introduce friction only when suspicious behavior is detected. By making the shift to Identity-First, organizations like Larimer County provide easy and seamless access for legitimate users, while decreasing the risk of security and compliance breaches.
Jessica Figueras, a cybercrime and digital identity advisor to governments and Okta consultant, said: “In the face of increasing digitization, skills shortages, and online harms, governments are taking a hard look at the technologies they can bring onboard to help them reach their digital goals. The research suggests that identity is one such technology that can help the public sector do more with less.”
To learn more and download the full report, please visit: 2022 Auth0 Public Sector Identity Index .
Methodology
Auth0 engaged Market Connections to design an online survey of 850 IT and line of business decision-makers within national and state/local governments in the U.S. (200 federal, 200 state & local), UK (100 federal, 100 state & local), and ANZ (Australia and New Zealand) (155 federal/national, 95 state & local), fielded in September-October 2021.
About Auth0
Auth0, a product unit within Okta, takes a modern approach to identity and enables organizations to provide secure access to any application, for any user. The Auth0 Identity Platform is highly customizable, and is as simple as development teams want, and as flexible as they need. Safeguarding billions of login transactions each month, Auth0 delivers convenience, privacy, and security so customers can focus on innovation. For more information, visit https://auth0.com .
About Okta
Okta is the leading independent identity provider. The Okta Identity Cloud enables organizations to securely connect the right people to the right technologies at the right time. With more than 7,000 pre-built integrations to applications and infrastructure providers, Okta provides simple and secure access to people and organizations everywhere, giving them the confidence to reach their full potential. More than 14,000 organizations, including JetBlue, Nordstrom, Siemens, Slack, Takeda, Teach for America, and Twilio, trust Okta to help protect the identities of their workforces and customers.
Disclaimer:
Research reports and related summaries referenced herein are provided for informational purposes only, and consist of the opinions of the organizations publishing such research and should not be construed as statements of fact. Okta and Auth0 make no representations, warranties, or other assurances with respect to such research.
1 Public Sector Predictions 2022, Forrester Research, Inc., November 3, 2021.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220112005037/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
